Skip to main content

Year: 2025

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b clinical trial. Portage had previously paused this trial due to funding concerns; this resumption of the trial underscores the encouraging findings observed in earlier cohorts. After the completion of the PORT-6 arm of the ADPORT-601 study, Portage will evaluate the continuation of the study into its PORT-7 (potent and...

Continue reading

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next-generation vaccine companies and a member of the Swiss Rockets Ltd family of companies, today announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets Ltd, the parent company of Rocketvax Ltd, to support research, infrastructure development, and the expansion of Swiss Rockets’ innovative biotechnology portfolio. This endeavor underscores Emergent’s commitment to supporting Swiss Rockets’ broader mission of pioneering breakthrough medical technologies. In addition to the investment, the parties intend to form a strategic...

Continue reading

BEN Supports California’s AI Data Privacy Bill

WILMINGTON, Del., March 12, 2025 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, has announced its support for California Assembly Member Carl DeMaio’s proposed AI data privacy legislation. This bill, which aims to secure the privacy of California residents, would require businesses to obtain explicit consent before sharing or storing user data outside the United States. As AI adoption accelerates across industries, the need for robust data protection has never been more critical. BEN recognizes the importance of securing user data and supports DeMaio’s initiative as a vital step in advancing privacy protections in the AI space. “Data privacy is a fundamental right, and it is crucial that we hold ourselves accountable in developing AI technologies,”...

Continue reading

Vera Bradley Announces Fourth Quarter Fiscal Year 2025 Results

Consolidated net revenues totaled $372.0 million for the fiscal year Financial condition remains strong with no debt and approximately $30 million in cash Management provides guidance for fiscal year 2026 Outlook anticipates fiscal 2026 year-end cash balance increasing to approximately $40 million FORT WAYNE, Ind., March 12, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the fourth quarter and fiscal year ended February 1, 2025 (“Fiscal 2025”). In this release, Vera Bradley, Inc. or “the Company” refers to the entire enterprise and includes both the Vera Bradley and Pura Vida brands. Vera Bradley on a stand-alone basis refers to the Vera Bradley brand. Fourth Quarter and Fiscal Year-End Comments Jackie Ardrey, Chief Executive Officer commented, “The fourth quarter...

Continue reading

NANO Nuclear Energy Expands its Regulatory and Safety Expertise with the Addition of Seasoned Professional Andrew Steer, Ph.D. as Head of Regulatory Engagement

Figure 1NANO Nuclear Energy Inc. Appoints Dr. Andrew Steer as Head of Regulatory Engagement.New York, N.Y., March 12, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced the addition of Andrew Steer, Ph.D., a recognized specialist in nuclear safety case development as its Head of Regulatory Engagement. Dr. Andrew Steer is a nuclear safety case and regulatory engagement expert with over 18 years of experience in the nuclear industry. Until recently, Dr. Steer served as Head of Licensing and Regulation at MoltexFLEX, a British nuclear energy company developing advanced small modular molten salt reactors. Dr. Steer led the strategy, scope and development of the...

Continue reading

Ocean Power Technologies Announces Binding Letter of Intent to Deploy AI-Capable PowerBuoy for a Major International Defense Contractor

MONROE TOWNSHIP, N.J., March 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it received a binding letter of intent to deploy a PowerBuoy® for an undisclosed customer to demonstrate the survivability and suitability of the system for certain multidomain defense and security applications in extreme sea conditions. This follows the signing of a teaming agreement with a major international defense contractor last year to provide its Merrows™ suite of solutions with a focus on certain geographic regions. Mr. Philipp Stratmann, CEO and President of Ocean Power Technologies, expressed enthusiasm about the deployment, stating, “We are excited to advance...

Continue reading

SAIC and Defense Unicorns Partner to Transform Software Delivery for the Department of Defense

Integration of UDS into SAIC ecosystem accelerates delivery of industry-leading software capabilities and expands offerings for defense customers RESTON, Va., March 12, 2025 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) and Defense Unicorns announced a strategic partnership to increase the delivery of secure, scalable and mission-critical software capabilities for the Department of Defense (DoD). Through this collaboration, SAIC will integrate Defense Unicorns’ Unicorn Delivery Service (UDS) into its existing, robust software delivery ecosystem, streamlining how SAIC deploys and maintains applications across cloud, on-premises and tactical edge environments – ultimately improving operational readiness for today’s warfighters. The DoD relies on software to support mission-critical operations across all...

Continue reading

Healthy Choice Wellness Provides Shareholder Update Highlighting Strategic Growth Drivers

HCWC expanding revenue streams while strengthening infrastructure and customer engagement  HOLLYWOOD, FL, March 12, 2025 (GLOBE NEWSWIRE) — Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company operating 19 natural and organic grocery stores across six states, provides a shareholder update highlighting its key growth drivers for 2025, which include operational efficiencies, new revenue streams, investment in key leadership roles and enhanced customer engagement. Healthy Choice Wellness Chairman and CEO Jeff Holman commented, “We are making strategic investments that position HCWC for sustainable growth. By fortifying our team, expanding revenue generation, and enhancing customer engagement, we continue to build a solid foundation for profitability. These initiatives not only drive financial growth...

Continue reading

Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management

Biotricity’s latest patents focus on a multi-biometric device platform that functions as both a patch and watch, advancing biometric monitoring solutions for remote patient care. REDWOOD CITY, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), (“Biotricity” or the “Company”), a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce the expansion of its intellectual property (IP) portfolio with 14 new patents. This brings the company’s total to 15 issued patents, with an additional 14 patents pending. The expansion of the company’s IP portfolio underscores Biotricity’s commitment to advancing and improving the patient journey. By streamlining diagnostic processes, Biotricity helps...

Continue reading

FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.

MINNEAPOLIS, MN, March 12, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company or FOXO”), provides an update on Myrtle Recovery Centers, Inc., (“Myrtle”) and its behavioral health facility in Oneida, Tennessee, and confirms participation in a major alcohol and drug addiction conference in East Tennessee. Myrtle is pleased to announce that its Oneida, Tennessee substance abuse treatment facility has reached stabilization by maintaining an occupancy rate of 75% or greater since the beginning of 2025. In addition, on occasion, the facility has been at capacity unable to accept additional patients over the same period. Myrtle has also, since the beginning of 2025, finalized a number of in-network contracts with major managed care organizations. Myrtle is also pleased to announce its participation as a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.